Artiva Biotherapeutics Ownership | Who Owns Artiva Biotherapeutics?
Artiva Biotherapeutics Ownership Summary
Artiva Biotherapeutics is owned by 1.16% institutional investors, 19.88% insiders, and 78.97% retail investors. Ra capital management is the largest institutional shareholder, holding 40.42% of ARTV shares.
ARTV Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Artiva Biotherapeutics | 1.16% | 19.88% | 78.97% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ra capital management | 9.85M | 40.42% | $28.28M |
| 5am venture management | 2.35M | 9.65% | $6.75M |
| Vr adviser | 1.61M | 6.60% | $4.62M |
| Venbio partners | 1.15M | 4.71% | $3.30M |
| Franklin resources | 520.33K | 2.13% | $2.23M |
| Vanguard group | 246.01K | 1.00% | $1.06M |
| Blackrock funding, inc. /de | 212.54K | 0.87% | $911.79K |
| Wellington management group llp | 194.11K | 0.80% | $557.09K |
| Renaissance | 116.20K | 0.47% | $498.50K |
| Geode capital management | 101.12K | 0.41% | $434.13K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| 5am venture management | 2.35M | 2.47% | $6.75M |
| Venbio partners | 1.15M | 1.87% | $3.30M |
| Ra capital management | 9.85M | 0.35% | $28.28M |
| Vr adviser | 1.61M | 0.26% | $4.62M |
| Xtx topco | 47.97K | 0.01% | $137.68K |
| Prelude capital management | 14.30K | 0.00% | $41.05K |
| Bridgeway capital management | 35.00K | 0.00% | $100.45K |
| Alyeska investment group | 100.00K | 0.00% | $287.00K |
| Renaissance | 116.20K | 0.00% | $498.50K |
| Tower research capital llc (trc) | 9.98K | 0.00% | $28.64K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 246.01K | - | 86.89K |
| Xtx topco | 47.97K | 0.01% | 47.97K |
| Jane street group | 40.67K | - | 40.67K |
| Renaissance | 116.20K | 0.00% | 37.05K |
| Ubs group | 36.87K | - | 15.73K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | - | - | -866.62K |
| Samsara biocapital | - | - | -291.67K |
| Woodline partners lp | - | - | -283.12K |
| Rtw investments, lp | - | - | -148.84K |
| Logos global management lp | - | - | -145.09K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Xtx topco | 47.97K | 0.01% | 47.97K | $137.68K |
| Prelude capital management | 14.30K | 0.00% | 14.30K | $41.05K |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -15.00 |
| Sterling capital management | -158.00 |
| Eversource wealth advisors | -159.00 |
| Cwm | -185.00 |
| Nelson, van denburg & campbell wealth management group | -224.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | -94.87% | 282,879 | -98.44% | 1 | 0.02% | 2 | -84.62% | - | -100.00% |
| Sep 30, 2025 | 7 | -85.11% | 274,587 | -98.52% | 1 | 0.02% | 4 | -80.95% | 3 | -80.00% |
| Jun 30, 2025 | 46 | -13.21% | 18,502,865 | -11.55% | 75 | 1.03% | 20 | -23.08% | 15 | 25.00% |
| Mar 31, 2025 | 53 | -7.02% | 20,919,893 | -1.14% | 185 | 0.53% | 26 | -7.14% | 12 | 100.00% |
| Dec 31, 2024 | 57 | 18.75% | 21,161,524 | 2.23% | 187 | 1.57% | 28 | -41.67% | 6 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 15, 2025 | Aslan Fred | President and CEO | Sell | $19.12K |
| Nov 17, 2025 | Aslan Fred | President and CEO | Sell | $21.52K |
| Oct 17, 2025 | Aslan Fred | President and CEO | Sell | $153.00K |
| Aug 15, 2025 | Aslan Fred | President and CEO | Sell | $69.58K |
| Jul 22, 2024 | RA CAPITAL MANAGEMENT, L.P. | Buy | $91.74M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
ARTV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools